Evidence map›Paper›PMID 33193170›Full record

ArticleFrontiers in microbiology2020

Prevalence and Molecular Epidemiology of Human T-Lymphotropic Virus (HTLV) Infection in People Living With HIV/AIDS in the Pará State, Amazon Region of Brazil.

Samira Peixoto Alencar, Marlinda de Carvalho Souza, Ricardo Roberto de Souza Fonseca, Cláudia Ribeiro Menezes, Vânia Nakauth Azevedo, Andre Luis Ribeiro Ribeiro, Sandra Souza Lima, Rogério Valois Laurentino, Maria Dos Anjos de Abreu Pina Barbosa, Felipe Bonfim Freitas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Samira Peixoto AlencarBiology of Infectious and Parasitic Agents Post-Graduate Program, Federal University of Pará, Belém, Brazil.
Marlinda de Carvalho SouzaBiology of Infectious and Parasitic Agents Post-Graduate Program, Federal University of Pará, Belém, Brazil.
Ricardo Roberto de Souza FonsecaBiology of Infectious and Parasitic Agents Post-Graduate Program, Federal University of Pará, Belém, Brazil.
Cláudia Ribeiro MenezesBiology of Infectious and Parasitic Agents Post-Graduate Program, Federal University of Pará, Belém, Brazil.
Vânia Nakauth AzevedoVirology Laboratory, Institute of Biological Sciences, Federal University of Pará, Belem, Brazil.
Andre Luis Ribeiro RibeiroVirology Laboratory, Institute of Biological Sciences, Federal University of Pará, Belem, Brazil.
Sandra Souza LimaVirology Laboratory, Institute of Biological Sciences, Federal University of Pará, Belem, Brazil.
Rogério Valois LaurentinoVirology Laboratory, Institute of Biological Sciences, Federal University of Pará, Belem, Brazil.
Maria Dos Anjos de Abreu Pina BarbosaEvandro Chagas Institute, Ministry of Health of Brazil, Ananindeua, Brazil.
Felipe Bonfim FreitasReference Unit Specialized in Infectious and Parasitic Diseases, Belém, Brazil.
Aldemir Branco Oliveira-FilhoVulnerable Populations Research Group, Institute for Coastal Studies, Federal University of Pará, Bragança, Brazil.
Luiz Fernando Almeida MachadoBiology of Infectious and Parasitic Agents Post-Graduate Program, Federal University of Pará, Belém, Brazil.
Universidade Federal do Pará · BRInstituto de Infectologia Emílio Ribas · BRMinistério da Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human T-lymphotropic virus (HTLV) is part of the group of retroviruses that share similar routes of transmission to the human immunodeficiency virus (HIV). Coinfection of these viruses can affect the clinical course of both infections, and reports have shown a quicker progression to AIDS and the development of HIV-related opportunistic infections. The current study investigated the demographic characteristics, prevalence, and the subtypes of HTLV among people living with HIV/AIDS (PLWHA) in the State of Pará, Northern Brazil. Blood samples were obtained from patients who were attending a reference unit that provides medical assistance to HIV-infected individuals in the State of Pará, Brazil, during the period of May 2016 to June 2017. Plasma samples were screened by ELISA tests to detect antibodies anti-HTLV-1/2. DNA and viral types were identified by real-time polymerase chain reaction (qPCR). All samples with viral DNA were submitted to nested PCR and nucleotide sequencing. The overall coinfection rate was 1.4% (5/368), and all samples were from subtype HTLV-1a. No cases of HTLV-2 infection were detected. The prevalence of HTLV-1 was higher in females (80%), individuals between 31 and 50 years of age, heterosexual, unmarried, with low monthly income, with secondary educational level or higher, sporadic condom usage, limited number of sexual partners, and no history of sexually transmitted infections. All samples from HTLV-1-infected patients were identified as strains belonging to the subtype 1a (Cosmopolitan), subgroup A (Transcontinental). This study identified that the prevalence of HIV/HTLV coinfection has dropped from 8 to 1.3% in the current investigation. There was a shift of HTLV subtype from a predominance of HTLV-2 infection in the past to an actual exclusively HTLV-1a. There was no significant association between economic, sociodemographic, and behavioral characteristics in HIV/HTLV coinfection.

Indexed as

Amazon regioncoinfectionepidemiologyHIVHTLVmolecular epidemiology

Identifiers

PMID33193170
PMCPMC7642294
OpenAlexW3093582084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.